|
Re: AGM/rumour mill?'s
|
4
|
Zenith Epigenetics
|
Oct 27, 2021 04:11PM
|
|
Re: IR
|
4
|
Resverlogix Corp.
|
Sep 12, 2017 12:39PM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
Oct 07, 2021 07:00PM
|
|
Re: The Way Forward
|
4
|
Resverlogix Corp.
|
Oct 23, 2017 09:47AM
|
|
Re: Dr Sweeney
|
4
|
Resverlogix Corp.
|
Jun 22, 2016 11:09AM
|
|
Re: Some thoughts on DM and the back and forth of compounds..
|
4
|
Resverlogix Corp.
|
Aug 30, 2015 10:06AM
|
|
Re: Fabry trial news, Halifax and Alberta's Children't Hospital slated....
|
4
|
Resverlogix Corp.
|
Jun 14, 2017 03:44PM
|
|
Re: This is a Drug for people at the end of their life...CHF and advanced kidney disease...so is Dementia next?
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 10:53AM
|
|
Re: Don's discount
|
4
|
Resverlogix Corp.
|
Feb 05, 2018 03:17PM
|
|
Re: A Homecoming of Sorts...book value question
|
4
|
Resverlogix Corp.
|
Sep 23, 2015 03:09PM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
4
|
Resverlogix Corp.
|
Jan 11, 2018 09:17AM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
4
|
Resverlogix Corp.
|
Jun 02, 2022 03:29PM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 07, 2018 07:24PM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
4
|
Resverlogix Corp.
|
Oct 04, 2023 01:25PM
|
|
Thoughts re AGM Agenda
|
4
|
Resverlogix Corp.
|
Jun 21, 2022 01:09PM
|
|
Re: At least RVX has a shorter trial timeline than ESPR
|
4
|
Resverlogix Corp.
|
May 05, 2016 05:05PM
|
|
Re: Wow talk about saying....
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 08:05PM
|
|
Epigenetics in the Sept 8th Globe and Mail
|
4
|
Zenith Epigenetics
|
Sep 10, 2018 02:07PM
|
|
Re: Array and Zenith
|
4
|
Zenith Epigenetics
|
Jun 22, 2019 12:26PM
|
|
Re: Accelerated approval
|
4
|
Zenith Epigenetics
|
Oct 17, 2019 12:43PM
|
